Randomized Controlled Trial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Mar 27, 2024; 16(3): 833-841
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.833
Whole-process case management effects on mental state and self-care ability in patients with liver cancer
Man-Di Ju, Qin Qin, Meng Li
Man-Di Ju, Department of Internal Medicine of Abdominal Oncology, Hubei Cancer Hospital, Wuhan 430070, Hubei Province, China
Qin Qin, Department of Hepatological Surgery, Wuhan No. 1 Hospital, Wuhan 430000, Hubei Province, China
Meng Li, Department of Nursing, General Hospital of the Yangtze River Shipping, Wuhan 430014, Hubei Province, China
Co-first authors: Man-Di Ju and Qin Qin.
Author contributions: Ju MD and Qin Q designed the research; Li M, Ju MD and Qin Q performed the research; Li M, Ju MD and Qin Q contributed new reagents/analytic tools; Li M, Ju MD and Qin Q analyzed the data; Ju MD and Qin Q wrote the paper; All authors were involved in the critical review of the results and have contributed to, read, and approved the final manuscript. Ju MD and Qin Q contributed equally to this work as co-first authors equally to this work. Ju MD and Qin Q contributed efforts of equal substance throughout the research process. The choice of these researchers as co-first authors acknowledges and respects this equal contribution, while recognizing the spirit of teamwork and collaboration of this study. In summary, we believe that designating Ju MD and Qin Q as co-first authors of are fitting for our manuscript as it accurately reflects our team’s collaborative spirit, equal contributions, and diversity.
Institutional review board statement: This study protocol was approved by the General Hospital of the Yangtze River Shipping, and all the families have voluntarily participated in the study and have signed informed consent forms.
Clinical trial registration statement: We have not registered URL number. We have the ethical certificate approved by the unit.
Informed consent statement: All the families have voluntarily participated in the study and have signed informed consent forms.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: Data generated from this investigation are available upon reasonable request from the corresponding author at limeng333321@163.com.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Meng Li, Nurse, Department of Nursing, General Hospital of the Yangtze River Shipping, No. 1 Huiji Road, Jiang’an District, Wuhan 430014, Hubei Province, China. limeng333321@163.com
Received: November 23, 2023
Peer-review started: November 23, 2023
First decision: December 18, 2023
Revised: December 22, 2023
Accepted: January 30, 2024
Article in press: January 30, 2024
Published online: March 27, 2024
Core Tip

Core Tip: Patients with liver cancer are likely to face different dilemmas and have differing psychological states at various stages of the disease. A definitive diagnosis of liver cancer can be a significant trauma for patients, with patients and their families often unable to cope for a certain period of time. Patients with liver cancer are prone to negative psychological emotions such as anxiety, depression, and fear. The whole-process case management was shown to effectively reduce the anxiety and depression in patients with liver cancer, reduce symptom distress and improve the level of hope, self-care ability, sleep quality and life quality, as well as provide feasible nursing alternatives for patients with liver cancer.